SARTORIUS STED BIO (EPA:DIM)

BRIEF

published on 07/02/2024 at 14:58, 4 months 19 days ago

Number of shares and voting rights of Sartorius Stedim Biotech SA

Share Capital Voting Rights Actions AMF Sartorius Stedim Biotech
PRESS RELEASE

published on 07/02/2024 at 14:53, 4 months 19 days ago

Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA declares number of shares and voting rights in the issued capital according to French regulations. Details in press release

Voting Rights Shares French Regulations Sartorius Stedim Biotech SA Issued Capital
BRIEF

published on 07/02/2024 at 11:30, 4 months 19 days ago

Half-year review of the Sartorius Stedim Biotech liquidity contract

Liquidity Kepler Cheuvreux AMF Transparency Sartorius
PRESS RELEASE

published on 07/02/2024 at 11:27, 4 months 19 days ago

Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech
Sartorius Stedim Biotech's half-year liquidity contract statement reveals significant shares and volume on June 30th, 2024. The company is a key player in the biopharmaceutical industry with a global presence

Liquidity Contract Shares Traded Volume Sartorius Stedim Biotech Biopharmaceutical Industry
PRESS RELEASE

published on 07/02/2024 at 11:25, 4 months 19 days ago

Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech
Sartorius Stedim Biotech SA reports half-year liquidity contract statement with details on executed shares, traded volumes, and resources, following AMF Decision N°2021-01

Shares Traded Volume Sartorius Stedim Biotech AMF Decision Half-year Liquidity Contract
BRIEF

published on 06/04/2024 at 10:15, 5 months 17 days ago

Publication of the Number of Shares and Voting Rights of Sartorius Stedim Biotech SA

Share Capital Voting Rights Actions AMF Sartorius Stedim Biotech
PRESS RELEASE

published on 06/04/2024 at 10:10, 5 months 17 days ago

Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA declares the number of shares and voting rights. The total number of shares is 97,330,405 with 165,579,822 total voting rights

Voting Rights Shares Sartorius Stedim Biotech SA Issued Capital French Regulatory News
BRIEF

published on 05/17/2024 at 19:37, 6 months 3 days ago

Sartorius Stedim Biotech unveils its strategy at Capital Markets Day

Business Strategy Webcast Sartorius Stedim Biotech Financial Forecast Capital Markets Day
PRESS RELEASE

published on 05/17/2024 at 19:32, 6 months 3 days ago

Sartorius Stedim Biotech Capital Markets: Links to presentation and webcast
Sartorius Stedim Biotech presented its business strategy and goals during Capital Markets Day, reaffirming its 2024 forecast and medium-term ambitions up to 2028. Links to presentation and webcast provided for broad access

Business Strategy Webcast Forecast Sartorius Stedim Biotech Capital Markets Day
BRIEF

published on 05/02/2024 at 15:39, 6 months 19 days ago

Sartorius Stedim Biotech Announces Share and Voting Rights Update

Share Capital Voting Rights Financial News Corporate Governance Sartorius Stedim Biotech

Published on 11/21/2024 at 17:35, 12 minutes ago

1upHealth Ranked Number 43 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500(TM)
Published on 11/21/2024 at 17:30, 17 minutes ago

SimpliGov and Proof Partner to Offer Online Notarization
Published on 11/21/2024 at 16:30, 1 hour 17 minutes ago

The Rise of DINKs: Dual-Income Couples Without Kids Redefine Financial Priorities in America
Published on 11/21/2024 at 16:01, 1 hour 46 minutes ago

Career Certified Extends Its Investment in the Fast-Growing Architecture, Engineering, and Construction (AEC) Professionals Market with Acquisition of My Contractors License
Published on 11/21/2024 at 16:00, 1 hour 47 minutes ago

Financial Independence Group Announces Exclusive Partnership With Power of Zero and Tax-Free Retirement Expert David McKnight

View all ACCESSWIRE

Published on 11/21/2024 at 16:00, 1 hour 47 minutes ago

Director/PDMR Shareholding
Published on 11/21/2024 at 15:41, 2 hours 5 minutes ago

Edison issues report on Murray Income Trust (MUT)
Published on 11/21/2024 at 15:24, 2 hours 23 minutes ago

Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Published on 11/21/2024 at 15:23, 2 hours 24 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Centamin plc
Published on 11/21/2024 at 15:22, 2 hours 25 minutes ago

Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc

View all EQS

Published on 11/21/2024 at 06:58, 10 hours 49 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 22 hours 27 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 10 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE

News